Medicare Enrolled

Seenu Hariprasad

Ophthalmology · Chicago, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
5841 S MARYLAND AVE, Chicago, IL 60637
8888240200
Registered in NPPES since 2006
NPI: 1639235880 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Hariprasad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Hariprasad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Hariprasad

Seenu Hariprasad is an ophthalmology specialist in Chicago, IL, with 19 years of NPI registration. Based on federal Medicare data, Hariprasad performed 2,061 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Hariprasad received a total of $2,153,219 from 23 pharmaceutical and/or device companies across 1439 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Hariprasad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 50% volume in IL $2,153,219 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,061
Medicare services
Top 50% in IL for ophthalmology
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
764 $21 $419
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
638 $64 $391
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
398 $74 $3,250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $74 $778
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $104 $578
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
47 $56 $334
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
37 $416 $3,649
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
36 $98 $1,062
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
12 $239 $7,507
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,153,219
Total received (2018-2024)
Avg $307,603/year across 7 years
Top 0% in IL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
1,439
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$301,121
2023
$358,875
2022
$342,249
2021
$244,346
2020
$207,622
2019
$410,959
2018
$288,046

Payments by company (2024)

Regeneron Healthcare Solutions, Inc.
$122,580
Astellas Pharma US Inc
$83,803
Coherus Biosciences Inc.
$32,483
Harrow Eye, LLC
$25,834
ABBVIE INC.
$18,370
Regeneron Pharmaceuticals, Inc.
$15,929
Apellis Pharmaceuticals, Inc.
$1,500
Alimera Sciences, Inc.
$465
Alcon Vision LLC
$115
EyePoint Pharmaceuticals US, Inc.
$42
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$743,707
Novartis Pharmaceuticals Corporation
$206,087
Allergan Inc.
$184,333
Alimera Sciences, Inc.
$139,038
Biogen, Inc.
$134,659
EyePoint Pharmaceuticals US, Inc.
$120,502
ABBVIE INC.
$116,668
Astellas Pharma US Inc
$113,758
Spark Therapeutics, Inc.
$80,308
Coherus Biosciences Inc.
$78,790
Allergan, Inc.
$63,854
Apellis Pharmaceuticals, Inc.
$40,842
Bausch & Lomb, a division of Bausch Health US, LLC
$32,501
Regeneron Pharmaceuticals, Inc.
$30,119
Harrow Eye, LLC
$25,834
Bausch & Lomb Americas Inc.
$14,389
AbbVie Inc.
$9,865
NOVARTIS PHARMACEUTICALS CORPORATION
$6,357
Novartis Pharma AG
$4,100
Alcon Research LLC
$3,451
Alcon Vision LLC
$1,946
VERTEX PHARMACEUTICALS INCORPORATED
$1,110
Alnylam Pharmaceuticals Inc.
$999
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
BEOVU · BROLUCIZUMAB · Cimerli · Constellation · DEXYCU · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IHEEZO · ILEVRO · ILUVIEN · Iluvien · Izervay · LUXTURNA · OZURDEX · RETISERT · Syfovre · VISUDYNE · VYZULTA · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Chicago?
Compare ophthalmologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
543
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Hariprasad is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Hariprasad experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Hariprasad performed 764 retinal imaging (oct scan) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Hariprasad receive payments from pharmaceutical companies?
Yes. Hariprasad received a total of $2,153,219 from 23 companies across 1,439 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Hariprasad's costs compare to other ophthalmologists in Chicago?
Hariprasad's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Hariprasad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →